PRESENCE OF HUMAN CHROMOSOME-1 WITH EXPRESSION OF HUMAN DECAY-ACCELERATING FACTOR (DAF) PREVENTS LYSIS OF MOUSE HUMAN HYBRID-CELLS BY HUMAN-COMPLEMENT

被引:11
|
作者
WANG, MW
WRIGHT, LJ
SIMS, MJ
WHITE, DJG
机构
[1] UNIV CAMBRIDGE,ADDENBROOKES HOSP,SCH CLIN,DEPT SURG,CAMBRIDGE CB2 2QQ,ENGLAND
[2] AFRC,INST ANIM PHYSIOL & GENET RES,DEPT IMMUNOL,CAMBRIDGE CB2 4AT,ENGLAND
关键词
D O I
10.1111/j.1365-3083.1991.tb01602.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Xenogeneic organs transplanted to phylogenetically distant species are subject to rapid destruction mediated by complement. In humans, the complement activation is regulated by several proteins encoded by a series of closely linked genes (RCA locus) located on chromosome 1. The mouse/human hybrid cell line B10 was found to have retained human chromosome 1. FACS analysis confirmed that RCA products such as decay-accelerating factor (DAF) were expressed on the membrane surface of B10 cells. When exposed to human or rabbit complement in the presence of naturally occurring human anti-mouse antibodies these cells were not lysed by human complement but were killed by rabbit complement. This effect could be abrogated by addition of anti-DAF monoclonal antibody (1C6). The results offer potential for genetic manipulation of the human complement regulatory products in animals to overcome xenograft hyperacute rejection.
引用
收藏
页码:771 / 778
页数:8
相关论文
共 50 条
  • [31] U1 SMALL NUCLEAR-RNA GENES ARE LOCATED ON HUMAN CHROMOSOME-1 AND ARE EXPRESSED IN MOUSE-HUMAN HYBRID-CELLS
    LUND, E
    BOSTOCK, C
    ROBERTSON, M
    CHRISTIE, S
    MITCHEN, JL
    DAHLBERG, JE
    MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (12) : 2211 - 2220
  • [32] Decay-accelerating factor transgenic mouse hearts are protected from human complement-mediated attack
    vanDenderen, BJW
    Pearse, MJ
    Aminian, A
    Adam, W
    Shinkel, TA
    dApice, AJF
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (02) : 583 - 584
  • [33] PROTECTION OF RAT ENDOTHELIAL-CELLS FROM PRIMATE COMPLEMENT-MEDIATED LYSIS BY EXPRESSION OF HUMAN CD59 AND/OR DECAY-ACCELERATING FACTOR
    CHARREAU, B
    CASSARD, A
    TESSON, L
    LEMAUFF, B
    NAVENOT, JM
    BLANCHARD, D
    LUBLIN, D
    SOULILLOU, JP
    ANEGON, I
    TRANSPLANTATION, 1994, 58 (11) : 1222 - 1229
  • [34] Effect of complement fragment 1 esterase inhibition on survival of human decay-accelerating factor pig lungs perfused with human blood
    Schröder, C
    Pfeiffer, S
    Wu, GS
    Zorn, GL
    Ding, L
    Allen, C
    Harrison, RA
    White, DJG
    Azimzadeh, AM
    Pierson, RN
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2003, 22 (12): : 1365 - 1375
  • [35] PRODUCTION OF PIGS TRANSGENIC FOR HUMAN DECAY-ACCELERATING FACTOR
    LANGFORD, GA
    YANNOUTSOS, N
    COZZI, E
    LANCASTER, R
    ELSOME, K
    CHEN, P
    RICHARDS, A
    WHITE, DJG
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (03) : 1400 - 1401
  • [36] Characterization of pigs transgenic for human decay-accelerating factor
    Cozzi, E
    Tucker, AW
    Langford, GA
    PinoChavez, G
    Wright, L
    OConnell, MJ
    Young, VJ
    Lancaster, R
    McLaughlin, M
    Hunt, K
    Bordin, MC
    White, DJG
    TRANSPLANTATION, 1997, 64 (10) : 1383 - 1392
  • [37] Structure/function studies of human decay-accelerating factor
    Brodbeck, WG
    Kuttner-Kondo, L
    Mold, C
    Medof, ME
    IMMUNOLOGY, 2000, 101 (01) : 104 - 111
  • [38] RE-EXPRESSION OF HUMAN GENES IN HUMAN-MOUSE HYBRID-CELLS
    BORDELON, MR
    SICILIANO, MJ
    KOHLER, PO
    JOURNAL OF CELL BIOLOGY, 1976, 70 (02): : A228 - A228
  • [39] DECAY-ACCELERATING FACTOR PROTECTS HUMAN TROPHOBLAST FROM COMPLEMENT-MEDIATED ATTACK
    CUNNINGHAM, DS
    TICHENOR, JR
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 74 (02): : 156 - 161
  • [40] DECAY-ACCELERATING FACTOR REGULATES COMPLEMENT-MEDIATED DAMAGE IN THE HUMAN ATHEROSCLEROTIC WALL
    NICULESCU, F
    RUS, HG
    VLAICU, R
    IMMUNOLOGY LETTERS, 1990, 26 (01) : 17 - 23